MICROCYSTIC LYMPHATIC MALFORMATION
Clinical trials for MICROCYSTIC LYMPHATIC MALFORMATION explained in plain language.
Never miss a new study
Get alerted when new MICROCYSTIC LYMPHATIC MALFORMATION trials appear
Sign up with your email to follow new studies for MICROCYSTIC LYMPHATIC MALFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a transplant drug tame tough vascular birthmarks?
Disease control CompletedThis phase 2 trial tested the drug sirolimus (rapamycin) in 61 children and young adults with complicated vascular anomalies—abnormal blood vessel growths that can cause pain, bleeding, or organ problems. The goal was to see if sirolimus could safely shrink these anomalies and im…
Matched conditions: MICROCYSTIC LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: Denise Martin Adams • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a transplant drug shrink Children's birthmarks?
Disease control CompletedThis study tested the drug sirolimus (rapamycin) in 63 children aged 6 to 18 with large, complicated slow-flow vascular malformations (abnormal blood or lymph vessels). Each child had an observation period followed by 4 to 8 months of sirolimus treatment. The main goal was to see…
Matched conditions: MICROCYSTIC LYMPHATIC MALFORMATION
Phase: PHASE2 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC